These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

44 related items for PubMed ID: 2377179

  • 1. New frontiers in the study of amyloidosis.
    Cohen AS, Skinner M.
    N Engl J Med; 1990 Aug 23; 323(8):542-3. PubMed ID: 2377179
    [No Abstract] [Full Text] [Related]

  • 2. [Mapping of amyloidosis by Iodine-123 labelled serum amyloid P component scintigraphy: myth or reality?].
    Hachulla E, Deveaux M, Duquesnoy B, Marchandise X.
    Rev Med Interne; 1994 Apr 23; 15(4):238-9. PubMed ID: 8059142
    [No Abstract] [Full Text] [Related]

  • 3. Amyloid proteins in pathogenesis of AA amyloidosis.
    Cunnane G.
    Lancet; 2001 Jul 07; 358(9275):4-5. PubMed ID: 11454365
    [No Abstract] [Full Text] [Related]

  • 4. Additional diagnostic value of SPECT/CT to planar Iodine-123 labeled serum amyloid P component scintigraphy in a patient with pulmonary nodular amyloidosis.
    Noordzij W, Glaudemans AW, van Rheenen RW, Dierckx RA, Slart RH, Hazenberg BP.
    Amyloid; 2014 Jun 07; 21(2):131-3. PubMed ID: 24479618
    [No Abstract] [Full Text] [Related]

  • 5. Imaging amyloidosis with radiolabelled SAP.
    Hawkins PN, Pepys MB.
    Eur J Nucl Med; 1995 Jul 07; 22(7):595-9. PubMed ID: 7498219
    [No Abstract] [Full Text] [Related]

  • 6. [Evaluation of primary amyloidosis using scintigraphy with the serum amyloid P component: from diagnosis to prognosis].
    Maulin L, Hachulla E, Facon T, Deveaux M, Blétry O, Vanhille P, Wechsler B, Godeau P, Levesque H, Marchandise W.
    Rev Med Interne; 1993 Jul 07; 14(10):962. PubMed ID: 8009058
    [Abstract] [Full Text] [Related]

  • 7. Lack of haemodialysis-associated amyloidosis.
    Zingraff J, Bardin T, Noël LH, Drüeke T.
    Lancet; 1991 Oct 26; 338(8774):1089. PubMed ID: 1681397
    [No Abstract] [Full Text] [Related]

  • 8. Occult adrenal insufficiency secondary to amyloidosis in the context of chronic renal failure.
    Harvey CJ, Gower PE, Hawkins PN, Pepys MB, Phillips ME.
    Nephrol Dial Transplant; 1995 Oct 26; 10(7):1237-9. PubMed ID: 7478132
    [No Abstract] [Full Text] [Related]

  • 9. In search of the ideal radiotracer for soft-tissue amyloid scanning.
    Lee VW, Shah NP.
    Amyloid; 2001 Sep 26; 8(3):220-1. PubMed ID: 11676299
    [No Abstract] [Full Text] [Related]

  • 10. Imaging of experimental amyloidosis with 131I-labeled serum amyloid P component.
    Caspi D, Zalzman S, Baratz M, Teitelbaum Z, Yaron M, Pras M, Baltz ML, Pepys MB.
    Arthritis Rheum; 1987 Nov 26; 30(11):1303-6. PubMed ID: 3689465
    [Abstract] [Full Text] [Related]

  • 11. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis.
    Saïle R, Deveaux M, Hachulla E, Descamps J, Duquesnoy B, Marchandise X.
    Eur J Nucl Med; 1993 Feb 26; 20(2):130-7. PubMed ID: 8440269
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.
    Hawkins PN, Lavender JP, Pepys MB.
    N Engl J Med; 1990 Aug 23; 323(8):508-13. PubMed ID: 2377176
    [Abstract] [Full Text] [Related]

  • 14. [Localized or systemic amyloidosis? Value and limitations of Iodine-123 labelled amyloid P component scintigraphy, role of biopsy of minor salivary glands].
    Hachulla E, Wechsler B, Deveaux M, Godeau P, Hatron PY, Devulder B, Janin A, Marchandise X.
    Rev Med Interne; 1994 Mar 23; 15(3):182-5. PubMed ID: 8059132
    [Abstract] [Full Text] [Related]

  • 15. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression.
    Hawkins PN, Richardson S, MacSweeney JE, King AD, Vigushin DM, Lavender JP, Pepys MB.
    Q J Med; 1993 Jun 23; 86(6):365-74. PubMed ID: 8171184
    [Abstract] [Full Text] [Related]

  • 16. Scintigraphy using iodine 123-labeled serum amyloid P component in ten patients with secondary AA type amyloidosis. A descriptive study.
    Feutrie ML, Hachulla E, Flipo RM, Huglo D, Maulin L, Deveaux M, Duquesnoy B, Delcambre B, Marchandise X.
    Rev Rhum Engl Ed; 1996 Dec 23; 63(11):866-9. PubMed ID: 9010977
    [No Abstract] [Full Text] [Related]

  • 17. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo.
    Hawkins PN.
    Clin Sci (Lond); 1994 Sep 23; 87(3):289-95. PubMed ID: 7955904
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Imaging amyloidosis in Still's disease.
    Hawkins P, Bloom SR, Cassar J, Cox TM, Pepys MB, Waxman J.
    BMJ; 1989 Sep 30; 299(6703):848-50. PubMed ID: 2510854
    [No Abstract] [Full Text] [Related]

  • 20. [Scintigraphy using amyloid P component labelled with iodine 123: a new method of evaluation of amyloidosis].
    Hachulla E, Deveaux M, Duquesnoy B, Marchandise X.
    Presse Med; 1994 Feb 19; 23(7):348. PubMed ID: 8208701
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.